Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-21

Clinical Trial Update: Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating collagen-thrombin matrix during cardiac surgery in coronary artery disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Collagen-thrombin matrix

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED